PALO ALTO, Calif. -- (BUSINESS WIRE) -- Affymax, Inc. (Nasdaq: AFFY) today announced that John Orwin, the company’s chief executive officer, will present at the 14th Annual BIO CEO & Investor Conference on Tuesday, February 14, 2012 at 3:00 p.m. Eastern Time in New York City.
A live webcast of the presentation will be available on the investors section of the Company's website at www.affymax.com. A replay will also be available for 30 days following the presentation.
About Affymax, Inc.
Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. For additional information, please visit www.affymax.com.
Affymax, Inc.
Corporate:
Sylvia Wheeler, 650-812-8861
Vice
President, Corporate Communications